These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. What is genital chlamydia? Chislett L Nurs Times; 2003 Sep 2-8; 99(35):46. PubMed ID: 14528761 [TBL] [Abstract][Full Text] [Related]
24. [Is screening for Chlamydia Trachomatis infection in all sexually active adolescent females appropriate?]. Anjot MN; Alvin P Arch Pediatr; 2005 Dec; 12(12):1773-4. PubMed ID: 16253489 [No Abstract] [Full Text] [Related]
25. Look out for the hidden STD. Rooney G; Robinson A Practitioner; 1997 Jul; 241(1576):372, 376, 379-80 passim. PubMed ID: 9425710 [No Abstract] [Full Text] [Related]
26. Which treatment for genital tract Chlamydia trachomatis infection? Tobin JM; Harindra V; Mani R Int J STD AIDS; 2004 Nov; 15(11):737-9. PubMed ID: 15537459 [TBL] [Abstract][Full Text] [Related]
27. Examination of the treatment and follow-up care for adolescents who test positive for Chlamydia trachomatis infection. Hwang LY; Tebb KP; Shafer MA; Pantell RH Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1162-6. PubMed ID: 16330741 [TBL] [Abstract][Full Text] [Related]
28. Comparative epidemiology of Chlamydia trachomatis infection among men attending sexually transmitted disease clinics with and without indication for testing. Rowhani-Rahbar A; Niccolai LM; Dunne DW; Green S; Jenkins H; Khoshnood K Int J STD AIDS; 2006 Jul; 17(7):453-8. PubMed ID: 16820074 [TBL] [Abstract][Full Text] [Related]
29. Snaring a silent threat. Chlamydia declining thanks to screening and prevention. Hobus P Adv Nurse Pract; 2002 Oct; 10(10):63-6. PubMed ID: 12424886 [No Abstract] [Full Text] [Related]
30. Re-infection of Chlamydia trachomatis in patients presenting to the genitourinary medicine clinic in Portsmouth: the chlamydia screening pilot study - three years on. Lee VF; Tobin JM; Harindra V Int J STD AIDS; 2004 Nov; 15(11):744-6. PubMed ID: 15537461 [TBL] [Abstract][Full Text] [Related]
32. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]. Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778 [TBL] [Abstract][Full Text] [Related]
35. Role of Chlamydia trachomatis in chronic prostatitis: diagnostic investigation and therapeutic experience with miocamycin. Rossi R; Mora A J Chemother; 1989 Jul; 1(4 Suppl):913-5. PubMed ID: 16312701 [No Abstract] [Full Text] [Related]
36. [Item no 95: sexually transmitted diseases: gonococcal and Chlamydia trachomatis urogenital infections (other than Nicolas-Favre disease]. CEDEF Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F59-63. PubMed ID: 18984230 [No Abstract] [Full Text] [Related]
37. [Systematic screening for Chlamydia trachomatis with the molecular biological AMP-CT test in urine samples from young women]. Orfila J; Mention JE; Sueur JM; Chaigneau C J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):555-7. PubMed ID: 12407326 [TBL] [Abstract][Full Text] [Related]
38. Issues in the management of sexually transmitted diseases in Papua New Guinea. Passey M P N G Med J; 1996 Sep; 39(3):252-60. PubMed ID: 9795576 [TBL] [Abstract][Full Text] [Related]